Michael Craig Diem Century Therapeutics, Inc. (IPSC) insider trading activity

IPSC Quotes by TradingView

Michael Craig Diem is Chief Financial Officer of Century Therapeutics, Inc.. Currently has a direct ownership of 253,533 shares of IPSC, which is worth approximately $646,509. The most recent transaction as insider was on Nov 01, 2023, when has been sold 20,763 shares (Common Stock) at a price of $1.49 per share, resulting in proceeds of $30,936. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 254K
0% 3M change
7.57% 12M change
Total Value Held $646,509

Michael Craig Diem Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 01 2023
SELL
Payment of exercise price or tax liability
$30,936 $1.49 p/Share
20,763 Reduced 7.57%
253,533 Common Stock
May 15 2023
BUY
Grant, award, or other acquisition
-
151,058 Added 35.51%
274,296 Common Stock
Feb 02 2023
BUY
Grant, award, or other acquisition
-
43,750 Added 26.2%
123,238 Common Stock
MCD

Michael Craig Diem

Chief Financial Officer
Philadelphia, PA

Track Institutional and Insider Activities on IPSC

Follow Century Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IPSC shares.

Notify only if

Insider Trading

Get notified when an Century Therapeutics, Inc. insider buys or sells IPSC shares.

Notify only if

News

Receive news related to Century Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on IPSC